Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of hospital admission
Admission procalcitonin measurements and microbiology results were available for 1040 hospitalized adults with coronavirus disease 2019 (from 48 902 included in the International Severe Acute Respiratory and Emerging Infections Consortium World Health Organization Clinical Characterisation Protocol...
Huvudupphovsmän: | Relph, K, Russell, CD, Fairfield, CJ, Horby, P |
---|---|
Övriga upphovsmän: | International Severe Acute Respiratory and Emerging Infections Consortium Coronavirus Clinical Characterisation Consortium (ISARIC4C) Investigators |
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
Oxford University Press
2022
|
Liknande verk
Liknande verk
-
Procalcitonin and other common biomarkers do not reliably identify patients at risk for bacterial infection after congenital heart surgery
av: D Souza, S, et al.
Publicerad: (2019) -
Clinical utility and measurement of procalcitonin
av: Samsudin, Intan Nureslyna, et al.
Publicerad: (2017) -
The novel coronavirus 2019 epidemic and kidneys
av: Naicker, S, et al.
Publicerad: (2020) -
Viral coinfections in hospitalized coronavirus disease 2019 patients recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK study
av: Vink, E, et al.
Publicerad: (2022) -
Excluding severe bacterial infection in neutrophilic dermatoses with systemic manifestations : negative predictive value of procalcitonin
av: Yew, Yik Weng, et al.
Publicerad: (2019)